Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871949 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults
A Phase 1 study, sponsored by Sequella.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT00871949 is a Phase 1 study that has completed, run by Sequella. The registered enrollment target is 19 participants.
The verdict
NCT00871949, a Phase 1 study, has completed, sponsored by Sequella.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of PNU-100480 (PF-02341272) after a single dose in healthy adult volunteers.
Interventions
- DRUG Placebo
- DRUG PNU-100480
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00871949
The ClinicalTrials.gov registry entry for NCT00871949 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequella, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00871949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00871949 about?
NCT00871949 is a clinical study titled "Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults". The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of PNU-100480 (PF-02341272) after a single dose in healthy adult volunteers.
What is the current status of trial NCT00871949?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2009-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00871949?
The interventions under investigation include: Placebo (DRUG), PNU-100480 (DRUG).
Who is sponsoring clinical trial NCT00871949?
This trial is sponsored by Sequella, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.